---
document_datetime: 2023-09-21 19:12:31
document_pages: 6
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/revasc-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
document_name: revasc-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 4.6847715
conversion_datetime: 2025-12-29 23:15:25.187192
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Revasc

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                                                                                                                                                                                  | Opinion/ Notification 1 issued on Commission Decision Issued amended on no   | 2 / Product Information affected 3   | Summary   |
|----------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------|--------------------------------------|-----------|
| IAIN/0033/G          | This was an application for a group of variations. C.I.9.a - Changes to an existing pharmacovigilance system as described in the DDPS - Change in the QPPV C.I.9.c - Changes to an existing pharmacovigilance system as described in the DDPS - Change of the back-up procedure of the QPPV C.I.9.h - Changes to an existing pharmacovigilance product | 19/10/2012                                                                   | n/a                                  |           |

<!-- image -->

<!-- image -->

Medicinal product no longer authorised

<!-- image -->

<div style=\"page-break-after: always\"></div>

|             | system as described in the DDPS - Other change(s) to the DDPS that does not impact on the operation of the pharmacovigilance system                                                                                                                                                                                                                                                                                                                                                |            |            |                        |
|-------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|
| IAIN/0032/G | This was an application for a group of variations. C.I.9.a - Changes to an existing pharmacovigilance system as described in the DDPS - Change in the QPPV C.I.9.c - Changes to an existing pharmacovigilance system as described in the DDPS - Change of the back-up procedure of the QPPV C.I.9.h - Changes to an existing pharmacovigilance system as described in the DDPS - Other change(s) to the DDPS that does not impact on the operation of the pharmacovigilance system | 03/05/2012 |            | n/a longer authorised  |
| IAIN/0031/G | This was an application for a group of variations. A.1 - Administrative change - Change in the name and/or address of the MAH C.I.9.c - Changes to an existing pharmacovigilance system as described in the DDPS - Change of the back-up procedure of the QPPV C.I.9.h - Changes to an existing pharmacovigilance system as described in the DDPS - Other change(s) to the DDPS that does not impact on the operation of the pharmacovigilance system product                      | 23/01/2012 | n/a no     | SmPC, Labelling and PL |
| II/0030     | C.I.8.a - Introduction of a new Pharmacovigilance system - which has not been assessed by the relevant NCA/EMA for another product of the same MAH                                                                                                                                                                                                                                                                                                                                 | 17/03/2011 | 20/04/2011 | Annex II               |

<div style=\"page-break-after: always\"></div>

| II/0028   | Change to the manufacturer of the active substance with consequential changes to the manufacturing process of the active substance. Change(s) to the manufacturing process for the active substance Change(s) to the test method(s) and/or specifications for the active substance Quality changes   | 19/11/2009         | 21/12/2009   | Annex II        | authorised                                                                                                                                                                                                                                                                                                                                                              |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------|--------------|-----------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0029   | Changes to the test methods for the active substance and for the finished product Change(s) to the test method(s) and/or specifications for the active substance Change(s) to the test method(s) and/or specifications for the finished product                                                      | 19/11/2009         | 25/11/2009   | longer          |                                                                                                                                                                                                                                                                                                                                                                         |
| IB/0027   | IB_36_a_Change in shape or dimensions of the container/closure - sterile ph. forms/biologicals                                                                                                                                                                                                       | 23/03/2009 product | n/a no       |                 |                                                                                                                                                                                                                                                                                                                                                                         |
| IA/0026   | IA_05_Change in the name and/or address of a manufacturer of the finished product                                                                                                                                                                                                                    | 20/09/2007         | n/a          | Annex II and PL |                                                                                                                                                                                                                                                                                                                                                                         |
| R/0025    | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                              | 26/04/2007         | 21/06/2007   |                 | Based on the CHMP review of the available information and on the basis of a re-evaluation of the benefit risk balance, the CHMP is of the opinion that the quality, safety and efficacy of this medicinal product continues to be adequately and sufficiently demonstrated and therefore considered that the benefit risk profile of Revasc continues to be favourable. |

<div style=\"page-break-after: always\"></div>

|         |                                                                                                                                                                                                                                                                          |            |            |                        | The CHMP is also of the opinion that the renewal can be granted with unlimited validity.   |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|--------------------------------------------------------------------------------------------|
| II/0021 | Quality changes                                                                                                                                                                                                                                                          | 22/02/2007 | 27/02/2007 |                        |                                                                                            |
| IA/0024 | IA_08_b_01_Change in BR/QC testing - repl./add. manuf. responsible for BR - not incl. BC/testing                                                                                                                                                                         | 29/11/2006 | n/a        | PL                     | authorised                                                                                 |
| IA/0022 | IA_07_a_Replacement/add. of manufacturing site: Secondary packaging site                                                                                                                                                                                                 | 23/11/2006 | n/a        |                        |                                                                                            |
| IA/0023 | IA_05_Change in the name and/or address of a manufacturer of the finished product                                                                                                                                                                                        | 23/11/2006 | n/a        |                        |                                                                                            |
| II/0020 | Change(s) to the test method(s) and/or specifications for the finished product                                                                                                                                                                                           | 26/01/2006 | 02/02/2006 | longer                 |                                                                                            |
| IB/0019 | IB_42_a_01_Change in shelf-life of finished product - as packaged for sale                                                                                                                                                                                               | 21/12/2005 | n/a no     | SmPC                   |                                                                                            |
| IB/0018 | The MAH applies for a new pack size for Revasc. The additional pack size proposed in this variation is one vial of Revasc (15 mg) and one ampoule of mannitol (0.5 ml). IB_41_a_02_Change in pack size - change in no. of units outside range of appr. pack size product | 31/05/2005 | 31/05/2005 | SmPC, Labelling and PL |                                                                                            |
| IA/0017 | Replacement of the manufacturing site responsible of secondary packaging to a new site. IA_07_a_Replacement/add. of manufacturing site: Secondary packaging site                                                                                                         | 27/05/2005 | n/a        |                        |                                                                                            |

<div style=\"page-break-after: always\"></div>

| T/0016   | Transfer of Marketing Authorisation                                                            | 25/08/2004   | 13/10/2004    | SmPC, Annex II, Labelling and PL   | Transfer from Aventis Pharma S.A. to Canyon Pharmaceuticals.   |
|----------|------------------------------------------------------------------------------------------------|--------------|---------------|------------------------------------|----------------------------------------------------------------|
| II/0012  | Update of Summary of Product Characteristics and Package Leaflet                               | 25/09/2003   | 27/01/2004    | SmPC, Labelling and PL             | authorised                                                     |
| I/0014   | 24_Change in test procedure of active substance                                                | 26/06/2003   | 01/07/2003    |                                    |                                                                |
| I/0015   | 25_Change in test procedures of the medicinal product                                          | 26/06/2003   | 01/07/2003    | longer                             |                                                                |
| R/0011   | Renewal of the marketing authorisation.                                                        | 30/05/2002   | 02/08/2002    |                                    |                                                                |
| II/0010  | Update of Summary of Product Characteristics and Package Leaflet                               | 19/10/2000   | 22/01/2001    | SmPC, Labelling and PL             |                                                                |
| II/0008  | Change(s) to the test method(s) and/or specifications for the finished product product         | 26/07/2000   | 02/08/2000 no |                                    |                                                                |
| I/0009   | 03_Change in the name and/or address of the marketing authorisation holder                     | 16/06/2000   | 01/08/2000    | SmPC, Labelling and PL             |                                                                |
| I/0006   | 24_Change in test procedure of active substance                                                | 15/03/2000   | n/a           |                                    |                                                                |
| I/0007   | 25_Change in test procedures of the medicinal product                                          | 15/03/2000   | n/a           |                                    |                                                                |
| I/0005   | 01_Change in or addition of manufacturing site(s) for part or all of the manufacturing process | 28/07/1999   | 29/07/1999    |                                    |                                                                |

<div style=\"page-break-after: always\"></div>

| I/0004   | 20_Extension of shelf-life as foreseen at time of authorisation                                  | 17/12/1998   | 12/03/1999   | SmPC                       |
|----------|--------------------------------------------------------------------------------------------------|--------------|--------------|----------------------------|
| N/0003   | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification) | 07/12/1998   | 26/01/1999   | PL                         |
| I/0001   | 01_Change following modification(s) of the manufacturing authorisation(s)                        | 11/06/1998   | 18/09/1998   | Annex II, Labelling and PL |
| T/0002   | Transfer of Marketing Authorisation                                                              | 11/06/1998   | 05/08/1998   | SmPC, Labelling and PL     |

## 20\\_Extension of shelf-life as foreseen at time of authorisation 17/12/1998 12/03/1999 SmPC Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification) 07/12/1998 26/01/1999 PL 01\\_Change following modification(s) of the manufacturing authorisation(s) 11/06/1998 18/09/1998 Annex II, Labelling and PL Transfer of Marketing Authorisation 11/06/1998 05/08/1998 SmPC, Labelling and PL Medicinal product no longer authorised